CCT374705

N/A

Report date: 2023/04/11 17:59:59
NME

Base Information

Drug NameCCT374705
Drug Alias NameCCT374705CCT-374705
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionB-cell lymphoma 6 protein inhibitors
TargetsB-cell lymphoma 6 protein
Therapy Area/IndicationsLymphoma, Large B-Cell, Diffuse
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited Kingdom
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesThe Institute Of Cancer Research, London
China Registration ClassN/A

Develop Information

Active CompaniesThe Institute Of Cancer Research, London
Inactive CompaniesN/A
Active IndicationsLymphoma, Large B-Cell, Diffuse
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A